[1] [1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］. CA:A Cancer Journal for Clinicians,2018,68(6):394—424.

[3] [3] Haowen S, Jennifer K. Hepatocellular carcinoma in the era of immunotherapy［J］. Current Problems in Cancer,2018,42(1):40—48.

[4] [4] Catharine M S, Michael J D, Barry R H, et al. National academy of clinical biochemistry laboratory medicine practice guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers［J］. Clinical Chemistry,2010,56(6):e1—e48.

[5] [5] Tothill I E. Biosensors for cancer markers diagnosis［J］. Seminars in Cell and Developmental Biology,2009,20(1):55—62.

[6] [6] Pirsaheb M, Mohammadi S, Salimi A. Current advances of carbon dots based biosensors for tumor marker detection, cancer cells analysis and bioimaging［J］. Trends in Analytical Chemistry,2019,115:83—99.

[7] [7] Catharine S. Practice guidelines for tumor marker use in the clinic［J］. Clinical Chemistry,2002,48(8):1151—1159.

[8] [8] Sadighbayan D, Sadighbayan K, Tohid-kia M R, et al. Development of electrochemical biosensors for tumor marker determination towards cancer diagnosis: recent progress［J］. Trends in Analytical Chemistry,2019,118:73—88.

[9] [9] Forner A, Llovet J M, Bruix J. Hepatocellular carcinoma［J］. The Lancet,2012,379(9822):1245—1255.

[10] [10] Eleftherios P D. Cancer biomarkers: can we turn recent failures into success［J］. Journal of the National Cancer Institute,2010,102(19):1462—1467.

[11] [11] Kal-Koshvandi A T. Recent advances in optical biosensors for the detection of cancer biomarker α-fetoprotein (AFP)［J］. Trends in Analytical Chemistry,2020,128:115920.

[12] [12] Chayvialle J A P, Ganguli P C. Radioimmunoassay of alpha-fetoprotein in human plasma［J］.The Lancet,1973,301(7816):1355—1357.

[13] [13] Marjatta U, Erkki R, Eva E. Two-site sandwich enzyme immunoassay with monoclonal antibodies to human alpha-fetoprotein［J］. Journal Immunological Methods,1981,42(1):11—15.

[14] [14] Bi Xiaodong, Liu Zhen. Facile preparation of glycoprotein-imprinted 96-well microplates for ELISA by boronate affinity-based oriented surface imprinting［J］. Analytical Chemistry,2014,86(1):959—966.

[15] [15] Bi S, Yan Y, Yang X, et al. Gold nanolabels for new enhanced chemiluminescence immunoassay of alpha-fetoprotein based on magnetic beads［J］. Chemistry-A European Journal,2009,15(18):4704—4709.

[16] [16] Cao Y L, Yuan R, Chai Y Q, et al. Ultrasensitive luminol electrochemiluminescence for protein detection based on in situ generated hydrogen peroxide as coreactant with glucose oxidase anchored AuNPs@MWCNTs labeling［J］. Biosensors Bioelectronics,2012,31(1):305—309.

[17] [17] Dadfar S M M, Sekula-Neuner S, Trouillet V, et al. Evaluation of click chemistry microarrays for immunosensing of alpha-fetoprotein (AFP)［J］. Beilstein Journal of Nanotechnology,2019,10(1):2505—2515.

[18] [18] Wu J, Fu Z F, Yan F, et al. Biomedical and clinical applications of immunoassays and immunosensors for tumor markers［J］. Trends in Analytical Chemistry,2007,26(7):679—688.

[19] [19] Hong G S, Antaris A L, Dai H J. Near-infrared fluorophores for biomedical imaging［J］. Nature Biomedical Engineering,2017,1(260):313—320.

[20] [20] Chang X H, Zhang J, Wu L H, et al. Research progress of near-infrared fluorescence immunoassay［J］. Micromachines,2019,10(6):422—442.

[27] [27] Sheppard C J R, Cogswell C J, Gu M. Signal strength and noise in confocal microscopy: factors influencing selection of an optimum detector aperture［J］. Scanning,1991,13(3):233—240.

[29] [29] National Committee for Clinical Laboratory Standards. Method comparison and bias estimation using patient samples, approved guideline-second edition. NCCLS document EP9-A2［LSBN1-56238-472-4］.USA,2002.